RUA Life Sciences Statistics

Total Valuation

RUA Life Sciences has a market cap or net worth of GBP 8.07 million. The enterprise value is 5.59 million.

Market Cap	8.07M
Enterprise Value	5.59M

Important Dates

The next estimated earnings date is Wednesday, March 12, 2025.

Earnings Date	Mar 12, 2025
Ex-Dividend Date	n/a

Share Statistics

RUA Life Sciences has 62.06 million shares outstanding. The number of shares has increased by 141.09% in one year.

Current Share Class	n/a
Shares Outstanding	62.06M
Shares Change (YoY)	+141.09%
Shares Change (QoQ)	+38.19%
Owned by Insiders (%)	13.30%
Owned by Institutions (%)	46.57%
Float	51.15M

Valuation Ratios

The trailing PE ratio is 33.76.

PE Ratio	33.76
Forward PE	n/a
PS Ratio	2.38
PB Ratio	1.03
P/TBV Ratio	1.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.56, with an EV/FCF ratio of -7.80.

EV / Earnings	27.13
EV / Sales	1.91
EV / EBITDA	12.56
EV / EBIT	63.50
EV / FCF	-7.80

Financial Position

The company has a current ratio of 6.47, with a Debt / Equity ratio of 0.15.

Current Ratio	6.47
Quick Ratio	4.79
Debt / Equity	0.15
Debt / EBITDA	2.64
Debt / FCF	-1.64
Interest Coverage	1.09

Financial Efficiency

Return on equity (ROE) is 3.52% and return on invested capital (ROIC) is 0.82%.

Return on Equity (ROE)	3.52%
Return on Assets (ROA)	0.76%
Return on Capital (ROIC)	0.82%
Revenue Per Employee	73,025
Profits Per Employee	5,150
Employee Count	40
Asset Turnover	0.40
Inventory Turnover	0.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.77% in the last 52 weeks. The beta is 1.10, so RUA Life Sciences's price volatility has been similar to the market average.

Beta (5Y)	1.10
52-Week Price Change	+5.77%
50-Day Moving Average	11.43
200-Day Moving Average	11.59
Relative Strength Index (RSI)	71.44
Average Volume (20 Days)	211,856

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RUA Life Sciences had revenue of GBP 2.92 million and earned 206,000 in profits. Earnings per share was 0.00.

Revenue	2.92M
Gross Profit	2.37M
Operating Income	88,000
Pretax Income	7,000
Net Income	206,000
EBITDA	445,000
EBIT	88,000
Earnings Per Share (EPS)	0.00

Full Income Statement

Balance Sheet

The company has 3.78 million in cash and 1.18 million in debt, giving a net cash position of 2.60 million or 0.04 per share.

Cash & Cash Equivalents	3.78M
Total Debt	1.18M
Net Cash	2.60M
Net Cash Per Share	0.04
Equity (Book Value)	7.99M
Book Value Per Share	0.13
Working Capital	5.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -668,000 and capital expenditures -48,000, giving a free cash flow of -716,000.

Operating Cash Flow	-668,000
Capital Expenditures	-48,000
Free Cash Flow	-716,000
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 81.10%, with operating and profit margins of 3.01% and 7.05%.

Gross Margin	81.10%
Operating Margin	3.01%
Pretax Margin	0.24%
Profit Margin	7.05%
EBITDA Margin	15.23%
EBIT Margin	3.01%
FCF Margin	n/a

Dividends & Yields

RUA Life Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-141.09%
Shareholder Yield	-141.09%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on September 1, 2003. It was a reverse split with a ratio of 0.1.

Last Split Date	Sep 1, 2003
Split Type	Reverse
Split Ratio	0.1

Scores

RUA Life Sciences has an Altman Z-Score of 0.22. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.22
Piotroski F-Score	n/a